Recent publications · Crossref
5 total works indexed
- Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
· 2018 · cited 5,595x
- Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
· 2015 · cited 5,256x
- Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
· 2024 · cited 4,059x
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer